NSE filing, NSE: ULTRACEMCO. Summary written from the filing by ALFA Finder's alert engine.
UltraTech Cement Ltd: key numbers
- Share price
- ₹11,104.00
- Market cap
- ₹3,27,212 Cr
- Revenue (annual)
- ₹88,512 Cr
- Net profit (annual)
- ₹8,166 Cr
- P/E (TTM)
- 37.2×Sector 31.3×
- Promoter holding
- 58.48%-0.85% QoQ
- FII holding
- 12.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from UltraTech Cement Ltd
All →UltraTech Cement Employee Stock Options
UltraTech Cement granted 3,536 stock options, including 3,220 Options and 316 PSUs, under its 2022 Employee Stock Option and Performance Stock Unit Scheme.
UltraTech Cement Price Movement Clarification
UltraTech Cement clarified that the recent material price movement in its shares is market-driven, confirming no undisclosed information or impending announcements triggered the movement.
UltraTech Cement Debt & Borrowing: ₹460.5 Cr
UltraTech Cement approved a corporate guarantee of up to USD 55 million (approx. ₹460.5 Crore) for UHG Holdings IFSC Private Limited to support its business operations.
- Value
- ₹460.5 Cr
UltraTech Cement Investor Presentation: Key Takeaways
UltraTech reports robust Q2FY27 performance with consolidated revenue of Rs. 23,024 Cr (+18.9% YoY) and PAT of Rs. 1,501 Cr (+21.3% YoY). The company focus remains on aggressive capacity expansion and cost control.
UltraTech Cement Debt & Borrowing: ₹522.5 Cr
UltraTech Cement's board approved a USD 55 mn (₹522.5 Cr) corporate guarantee for associate UHG Holdings IFSC. The contingent liability supports UHG Holdings' business loan.
- Value
- ₹522.5 Cr
UltraTech Cement Management Change
UltrTech Cement's Vice Chairman K.K. Maheshwari steps down w.e.f. January 2027. MD K.C. Jhanwar re-designated as Non-Executive Vice Chairman after his MD term expires.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date